Barclays
GCO icon

Barclays’s Genesco GCO Stock Holding History

Barclays’s Portfolio GCO Stock Details GCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.6K Sell
1,380
-464
-25% -$16.3K ﹤0.01% 4342
2026
Q1 		$53.5K Sell
1,844
-14,824
-89% -$426K ﹤0.01% 4293
2025
Q4 		$413K Buy
16,668
+2,668
+19% +$76.5K ﹤0.01% 3950
2025
Q3 		$406K Sell
14,000
-3,628
-21% -$99.8K ﹤0.01% 3927
2025
Q2 		$347K Buy
17,628
+5,493
+45% +$115K ﹤0.01% 3966
2025
Q1 		$258K Sell
12,135
-10,093
-45% -$351K ﹤0.01% 3907
2024
Q4 		$950K Buy
22,228
+1,498
+7% +$49.2K ﹤0.01% 3408
2024
Q3 		$563K Buy
20,730
+10,521
+103% +$292K ﹤0.01% 3698
2024
Q2 		$264K Sell
10,209
-4,330
-30% -$113K ﹤0.01% 3416
2024
Q1 		$409K Sell
14,539
-11,911
-45% -$344K ﹤0.01% 3711
2023
Q4 		$931K Buy
26,450
+18,059
+215% +$555K ﹤0.01% 3482
2023
Q3 		$259K Sell
8,391
-4,354
-34% -$124K ﹤0.01% 3171
2023
Q2 		$319K Buy
12,745
+46
+0.4% +$1.33K ﹤0.01% 3006
2023
Q1 		$468K Sell
12,699
-17,711
-58% -$776K ﹤0.01% 3315
2022
Q4 		$1.4M Sell
30,410
-17,663
-37% -$801K ﹤0.01% 2532
2022
Q3 		$1.89M Buy
48,073
+435
+0.9% +$23.2K ﹤0.01% 1788
2022
Q2 		$2.38M Buy
47,638
+23,219
+95% +$1.39M ﹤0.01% 1732
2022
Q1 		$1.55M Sell
24,419
-5,874
-19% -$382K ﹤0.01% 2067
2021
Q4 		$1.95M Buy
30,293
+16,306
+117% +$1.04M ﹤0.01% 2396
2021
Q3 		$808K Sell
13,987
-3,517
-20% -$209K ﹤0.01% 2907
2021
Q2 		$1.11M Sell
17,504
-1,077
-6% -$58.4K ﹤0.01% 2588
2021
Q1 		$883K Sell
18,581
-7,923
-30% -$341K ﹤0.01% 2850
2020
Q4 		$797K Sell
26,504
-19,322
-42% -$494K ﹤0.01% 2919
2020
Q3 		$987K Buy
45,826
+26,507
+137% +$519K ﹤0.01% 2709
2020
Q2 		$418K Sell
19,319
-11,634
-38% -$215K ﹤0.01% 3482
2020
Q1 		$413K Sell
30,953
-11,974
-28% -$404K ﹤0.01% 3741
2019
Q4 		$2.06M Sell
42,927
-5,396
-11% -$224K ﹤0.01% 2973
2019
Q3 		$1.93M Sell
48,323
-14,465
-23% -$558K ﹤0.01% 2909
2019
Q2 		$2.65M Sell
62,788
-14,815
-19% -$655K ﹤0.01% 2579
2019
Q1 		$3.53M Buy
77,603
+41,932
+118% +$1.92M ﹤0.01% 1977
2018
Q4 		$1.58M Sell
35,671
-19,984
-36% -$863K ﹤0.01% 2643
2018
Q3 		$2.62M Buy
55,655
+32,291
+138% +$1.41M ﹤0.01% 2556
2018
Q2 		$928K Buy
23,364
+9,489
+68% +$404K ﹤0.01% 3365
2018
Q1 		$563K Sell
13,875
-11,907
-46% -$442K ﹤0.01% 3854
2017
Q4 		$839K Buy
25,782
+8,554
+50% +$235K ﹤0.01% 3290
2017
Q3 		$459K Sell
17,228
-1,205
-7% -$34.1K ﹤0.01% 3707
2017
Q2 		$624K Sell
18,433
-9,053
-33% -$404K ﹤0.01% 3308
2017
Q1 		$1.52M Buy
27,486
+10,639
+63% +$634K ﹤0.01% 2341
2016
Q4 		$1.05M Buy
16,847
+1,987
+13% +$121K ﹤0.01% 2693
2016
Q3 		$809K Sell
14,860
-46,677
-76% -$2.94M ﹤0.01% 2824
2016
Q2 		$3.96M Buy
61,537
+4,510
+8% +$298K 0.01% 1482
2016
Q1 		$4.11M Buy
57,027
+38,553
+209% +$2.49M 0.01% 1332
2015
Q4 		$1.03M Sell
18,474
-3,193
-15% -$185K ﹤0.01% 2586
2015
Q3 		$1.24M Buy
21,667
+4,718
+28% +$293K ﹤0.01% 2520
2015
Q2 		$1.12M Sell
16,949
-56
-0.3% -$3.84K ﹤0.01% 2791
2015
Q1 		$1.21M Sell
17,005
-8,016
-32% -$581K ﹤0.01% 2797
2014
Q4 		$1.9M Buy
25,021
+18,690
+295% +$1.42M ﹤0.01% 2575
2014
Q3 		$468K Buy
6,331
+202
+3% +$16.1K ﹤0.01% 4009
2014
Q2 		$501K Buy
6,129
+2,105
+52% +$161K ﹤0.01% 3973
2014
Q1 		$298K Sell
4,024
-4,259
-51% -$309K ﹤0.01% 4408
2013
Q4 		$604K Sell
8,283
-7,453
-47% -$521K ﹤0.01% 3907
2013
Q3 		$1.02M Sell
15,736
-5,554
-26% -$380K ﹤0.01% 3331
2013
Q2 		$1.43M Buy
+21,290
New +$1.37M ﹤0.01% 2930

Other funds holding GCO

Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
F1I
Fund 1 Investments Rincon, Puerto Rico $603M AUM 62.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Barclays's GCO Position: Q2 2026 in Review

Barclays reduced its Genesco (GCO) stake by 25% in Q2 2026, selling an estimated $16.3K and leaving 1,380 shares worth $46.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4342.

Barclays first reported a position in GCO in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.11M in Q1 2016. 142 funds tracked by Wall St. Rank hold GCO as of Q2 2026.

  • Barclays held 1,380 shares of Genesco worth $46.6K as of Q2 2026.
  • Barclays sold 464 Genesco shares in Q2 2026, an estimated $16.3K.
  • Genesco made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4342 holding.
  • Barclays first reported a position in Genesco in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Genesco position peaked at $4.11M in Q1 2016.
  • 142 funds tracked by Wall St. Rank held Genesco as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.